AI accelerates search for cancer therapeutics in Korea
Artificial intelligence (AI) has helped SK Telecom and SK Biopharmaceuticals identify promising early compounds for a targeted cancer therapy in just five months, a breakthrough the companies said…
Read the full articleYou might also wanna read
SKT, SK Biopharm Use AI to Cut Drug Discovery Time by 60%
SK Telecom and SK Biopharmaceuticals used AI to discover two early lead compounds for intractable cancer therapies, cutting drug research ti
AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
Featured content
drugtargetreview.com·5mo ago
CMU Startup Pierogi Therapeutics Uses AI to Accelerate Radiopharmaceutical Cancer Drug Discovery
A Carnegie Mellon University startup is using advanced chemistry and artificial intelligence to help speed up the search for new cancer drug
cmu.edu·1mo ago
VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline
Ardigen platform supports VERAXA’s in-house AI capabilities to optimize cancer target pair selection for conditionally active t cell engager
Pharma’s AI Boom Has Bet on the Wrong Bottleneck
Investors have poured billions into using artificial intelligence to discover new drugs, and 2026 is the first real test of whether AI-desig
Telecom Carriers Turn to Physical AI Trials for New Growth
SK Telecom and KT have begun building next-generation "Hyper-AI Networks" to run physical AI robots at high-risk industrial sites such as sh
Comments
Sign in to join the conversation.
No comments yet. Be the first.